Auxagen

Developing TGF-β therapeutics for wound healing, fibrosis, and cardiovascular diseases

placeSt. Louis, Missouri, United States calendar_todayFounded 2004 language auxagen.com

Innovation

4 patent families (3 granted) — focus: Human necessities; filing pace dormant. Cited 450 times.

YearFilings
20123
20131
20142
20152
20161

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon